Hjem › Brystkreft › Arizona › Gilbert
Kliniske studier for Brystkreft i Gilbert, AZ
9 studier for Brystkreft søker deltakere på steder i og rundt Gilbert (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruttererFase 1
- Research Site, Gilbert
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Banner MD Anderson Cancer Center ( Site 0066), Gilbert
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruttererFase 3
- Banner MD Anderson Cancer Center-Oncology ( Site 0004), Gilbert
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Ironwood Cancer & Research Centers, Gilbert
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
RekruttererFase 3
- Banner Health MD Anderson AZ, Gilbert
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Banner MD Anderson Cancer Center, Gilbert
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruttererFase 3
- Banner MD Anderson Cancer Center, Gilbert
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Ironwood Cancer & Research Centers, Gilbert
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
RekruttererObservasjonsstudie
- Banner - MD Anderson Cancer Center, Gilbert
Brystkreft-studier i andre byer
- New York City, NY134 studier
- Houston, TX126 studier
- Boston, MA111 studier
- Nashville, TN80 studier
- Los Angeles, CA72 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Durham, NC63 studier
- Queens, NY63 studier
- Chicago, IL58 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Gilbert
- Ikke-småcellet lungekreft12 studier
- Kolorektal kreft9 studier
- Lungekreft8 studier
- Kreft (alle typer)8 studier
- Plateepitelcancer i hode og hals6 studier
- Metastatisk kreft6 studier
- Multipelt myelom6 studier
- Hjertesvikt6 studier
- Kardiovaskulær sykdom6 studier
- Blærekreft6 studier
- Non-Hodgkins lymfom5 studier
- Diffust stort B-cellelymfom5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.